Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study-Reference-Cited by-同舟云学术

Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study

Published:2007-05-04 Issue:7 Volume:20 Page:722-728
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Rocca Paolo Cossu,Brunelli Matteo,Gobbo Stefano,Eccher Albino,Bragantini Emma,Mina Maria M,Ficarra Vincenzo,Zattoni Filiberto,Zamò Alberto,Pea Maurizio,Scarpa Aldo,Chilosi Marco,Menestrina Fabio,Bonetti Franco,Eble John N,Martignoni Guido

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/3800828.pdf

Reference34 articles.

1. Cheville JC, Lohse CM, Zincke H, et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003;27:612–624.

2. Moch H, Gasser T, Amin MB, et al. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer 2000;89:604–614.

3. Amin MB, Amin MB, Tamboli P, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 2002;26:281–291.

4. Ficarra V, Martignoni G, Galfano A, et al. Prognostic role of the histologic subtypes of renal cell carcinoma after slide revision. Eur Urol 2006;50:786–794.

5. Ficarra V, Martignoni G, Lohse C, et al. External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma. J Urol 2006;175:1235–1239.

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of microRNA-363 during tumor progression and invasion;Journal of Physiology and Biochemistry;2024-05-01

2. Development of a Single Molecule Counting Assay to Differentiate Chromophobe Renal Cancer and Oncocytoma in Clinics;Cancers;2022-07-01

3. Development of a Single Molecule Counting Assay to Differentiate Chromophobe Renal Cancer and Oncocytoma in Clinics;2022-05-16

4. Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer;International Journal of Molecular Sciences;2022-02-26

5. Kidney;Handbook of Practical Immunohistochemistry;2022